MedTrace Logo

Mental Contrasting With Implementation Intentions for Alcohol Use Disorders

NCT03684798 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2020-02-05

No results posted yet for this study

Summary

Mental Contrasting (MC) consists of imaging a desired future and comparing it with obstacles of the present reality in order to increase goal commitment when expectations of success are high. The study aims to investigate the effects of a motivational training (Mental Contrasting with Implementation Interventions; MCII) as a therapeutic add-on to standard treatment in inpatients with Alcohol Use Disorders.

Conditions

Interventions

OTHER

MCII

In this study, the research staff will work through the MCII approach with the participant as an interactive, face-to-face training. The desired future consists of imaging an abstinent life and comparing it with personally relevant obstacles. Afterwards, the most relevant obstacle will be chosen and an if-then-plan will be formed, that refers to this obstacle.

OTHER

Treatment as usual

The patients in the control group will receive a 2 x 2 contingency table about the disadvantages and advantages of being abstinent and of drinking. In addition, abstinence intentions of patients in the control group will also be supported and risk situations and relapse events since the last trainings will be reappraised, but without the use of MCII.

Sponsors & Collaborators

  • University of Konstanz

    collaborator OTHER

  • Zurich University of Applied Sciences

    collaborator OTHER

  • New York University

    collaborator OTHER

  • University of Hamburg-Eppendorf

    collaborator OTHER

  • Susanne Rösner

    lead OTHER

Principal Investigators

  • Susanne Rösner · Forel Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-14
Primary Completion
2019-03-04
Completion
2019-03-04

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03684798 on ClinicalTrials.gov